Preclinical Respiration and Inhalation Lab Equipment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 158 SKU: IRTNTR44890

Preclinical Respiration and Inhalation Lab Equipment Market 2024-2028

The preclinical respiration and inhalation lab equipment market size is forecast to increase by USD 4.16 million, at a CAGR of 4.29% between 2023 and 2028

There has been an increase in research on respiratory diseases across the globe. In addition, the market is witnessing an increase in respiratory research, which can be attributed to the growing investments in R&D activities focused on respiratory diseases. Furthermore, substantial advances have been made toward understanding the basic mechanisms of pulmonary diseases as well as optimizing their clinical management, as respiratory diseases are a major public health concern globally. Hence, such factors are positively impacting the market.

Technavio has segmented the market into Type, End-user, and Geography

  • The type segment is classified into respiration equipment and inhalation equipment
  • The end-user segment is classified into CROs and academic institutes and pharma and biotech companies
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Respiration and Inhalation Lab Equipment Market During the Forecast Period?

To learn more about this report, Download Report Sample

Preclinical Respiration and Inhalation Lab Equipment Market Segmentation by Type, End-user, and Geography Analysis

Type Analysis

Respiration equipment

The respiration equipment segment is estimated to witness significant growth during the forecast period. Respiration equipment is referred to as a collection of instruments and gadgets used to measure, track, and examine respiratory parameters in living things. In addition, this apparatus is frequently used to evaluate different facets of respiratory function in scientific, medical, and preclinical research contexts.

Get a glance at the market contribution of various segments Download PDF Sample

The respiration equipment segment was the largest segment and was valued at USD 12.93 billion in 2018. Moreover, devices for measuring tidal volume, respiratory rate, minute ventilation, and gas exchange are examples of equipment used in respiration measurements. In addition, it might also entail using specialized equipment to perform experiments on respiratory physiology and pathology, evaluate lung function, and investigate the effects of substances inhaled. Furthermore, research on respiratory health in general, drug development, inhalation toxicology studies, and respiratory diseases all greatly benefit from the equipment. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis

CROs and academic institutes

Preclinical respiration and inhalation lab equipment are extensively adopted for respiratory research as well as drug discovery. In addition, several pharmaceutical companies, big and small, have been outsourcing work to contract research organizations (CROs), while academic institutes that lack the infrastructure or equipment for performing certain tasks, also depend on outsourcing. Moreover, several academic institutes also prefer to perform all the preclinical respiratory research-related tasks on their premises for better monitoring and control over experiments. Furthermore, biopharmaceutical companies are increasingly dependent on CROs for services in the areas of preclinical and clinical research as well as drug discovery due to the high pressure on them to improve the productivity of their R&D activities. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Pharma and biotech companies

Some of the major pharmaceutical and biotechnology companies have developed the infrastructure needed to conduct experiments/research related to drug discovery as well as preclinical and clinical studies, due to the lack of a robust structural framework among CROs, which are not equipped enough to meet the rising demand from them. In addition, many major pharmaceutical companies that work on medicines to treat respiratory conditions acquire small-scale CROs to perform in-house respiratory-related research activities. Moreover, factors such as adverse working conditions and the increasing number of underpaid staff in the facilities of numerous CROs are facilitating pharmaceutical and biotechnology companies to opt to conduct respiratory-related research activities in their premises. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 48% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The large market share of North America in 2023 in the global preclinical respiration and inhalation lab equipment market is fuelled by the rising spending on R&D, the increasing focus on respiratory research, and the presence of key market players with their headquarters in the region. In addition, in North America, a significant number of people suffer from respiratory disorders, such as asthma, COPD, lung cancer, pneumonia, and chronic sinusitis.

Moreover, most of these respiratory diseases are primarily caused by genetic mutations and medical history, dust, air pollution, tobacco smoke, and occupational chemicals. Therefore., this has led to a substantial demand for respiratory research, which, in turn, has resulted in a rapid rise in the R&D expenditure on respiratory research to study pulmonary function. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Preclinical Respiration and Inhalation Lab Equipment Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market companies, including:

4DMedical Ltd: The company offers preclinical respiration and inhalation lab equipment namely XV Technology. Additionally, XY technology can be used for imaging lung function by using hospital imaging systems and X ray images from different angles.

  • ADInstruments Pty Ltd.
  • Bruker Corp.
  • CH Technologies USA Inc.
  • Columbus Instruments LLC
  • CWE
  • emka TECHNOLOGIES
  • EMMS
  • Harvard Bioscience Inc.
  • IN TOX PRODUCTS LLC
  • Kent Scientific Corp.
  • Koninklijke Philips N.V.
  • Lab Products Inc.
  • NuAire Inc.
  • TSE Systems GmbH
  • Vivotecnia
  • RWD Life Science Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Preclinical Respiration and Inhalation Lab Equipment Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Preclinical Respiration and Inhalation Lab Equipment Market Drivers

One of the key factors driving the preclinical respiration and inhalation lab equipment market growth is the growing prevalence of respiratory disorders. Chronic respiratory diseases, including chronic obstructive respiratory disease (COPD) and asthma, affect the airways and lungs. In addition, they are primarily caused by dust, air pollution, tobacco smoke, and exposure to occupational chemicals.  Furthermore, patients with chronic respiratory diseases, such as COPD and asthma, are advised to undergo continuous monitoring to identify the associated risks.

Moreover, the prevalence of chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is increasing across the globe. In addition, the prevalence of respiratory diseases, such as asthma and COPD, is specifically high among geriatric people as the strength of the respiratory muscles declines with age. Furthermore, the risks associated with respiratory disorders, such as diabetes, smoking, and obesity, are also on the rise. Hence, such factors are driving the market growth during the forecast period.

Significant Preclinical Respiration and Inhalation Lab Equipment Market Trends

A key factor shaping the preclinical respiration and inhalation lab equipment market growth is the growing popularity of minimally invasive techniques in respiratory research. With the increasing prevalence of respiratory disorders, including asthma, COPD, and infectious respiratory diseases, more research on lung function is becoming essential for drug discovery as well as other purposes. In addition, pulmonary function is a relevant endpoint in both pharmacological and toxicological studies on respiratory diseases.

Moreover, the assessment of drug effects on vital organ systems, such as the respiratory system, requires the use of non-invasive or minimally invasive techniques in conscious rodents, where the use of anesthesia is not necessary. Therefore, minimally invasive techniques are gaining prominence in respiratory research. Hence, such factors are driving the market growth during the forecast period.

Major Preclinical Respiration and Inhalation Lab Equipment Market Challenges

Limitations of animal studies are one of the key challenges hindering the preclinical respiration and inhalation lab equipment market growth. Although animal specimens are often beneficial and are increasingly utilized in respiratory research, there are various limitations to animal studies. In addition,  one of the major limitations that scientists face during respiratory research is the inability to replicate animal studies in human trials.

Moreover, this can be attributed to the poor design of the procedures in experiments, the choice of incorrect approaches while conducting the procedures in the lab environment, or the inaccurate analysis of the measurements. Furthermore, animal specimens, such as mice, offer promising potential for assessing the effects of drugs, mediators, and infectious agents on the human lungs and their function. Hence, such factors are negatively impacting the market which in turn hinders the market growth during the forecast period.

Buy Now Full Report

Key Preclinical Respiration and Inhalation Lab Equipment Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Preclinical Respiration and Inhalation Lab Equipment Market Customer Landscape

Segment Overview

The preclinical respiration and inhalation lab equipment market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Respiration equipment
    • Inhalation equipment
  • End-user Outlook
    • CROs and academic institutes
    • Pharma and biotech companies
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Preclinical Respiration and Inhalation Lab Equipment Market Scope

Report Coverage

Details

Page number

158

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.29%

Market Growth 2024-2028

USD 4.16 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.65

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Germany, France, UK, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, Kent Scientific Corp., Koninklijke Philips N.V., Lab Products Inc., NuAire Inc., TSE Systems GmbH, Vivotecnia, and RWD Life Science Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Preclinical Respiration and Inhalation Lab Equipment Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the preclinical respiration and inhalation lab equipment market  between 2023 and 2028
  • Precise estimation of the preclinical respiration and inhalation lab equipment market size and its contribution to the market in focus on the parent market
  • Detailed market research and growth of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough market growth and forecasting of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report of factors that will challenge the growth of preclinical respiration and inhalation lab equipment market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global preclinical respiration and inhalation lab equipment market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global preclinical respiration and inhalation lab equipment market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Respiration equipment - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Respiration equipment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Respiration equipment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Respiration equipment - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Respiration equipment - Year-over-year growth 2023-2028 (%)
    • 6.4 Inhalation equipment - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Inhalation equipment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Inhalation equipment - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Inhalation equipment - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Inhalation equipment - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 CROs and academic institutes - Market size and forecast 2023-2028
      • Exhibit 48: Chart on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on CROs and academic institutes - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on CROs and academic institutes - Year-over-year growth 2023-2028 (%)
    • 7.4 Pharma and biotech companies - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Pharma and biotech companies - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Pharma and biotech companies - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by End-user
      • Exhibit 56: Market opportunity by End-user ($ billion)
      • Exhibit 57: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 France - Market size and forecast 2023-2028
      • Exhibit 87: Chart on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 China - Market size and forecast 2023-2028
      • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ billion)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 4DMedical Ltd
              • Exhibit 107: 4DMedical Ltd - Overview
              • Exhibit 108: 4DMedical Ltd - Product / Service
              • Exhibit 109: 4DMedical Ltd - Key offerings
            • 12.4 ADInstruments Pty Ltd.
              • Exhibit 110: ADInstruments Pty Ltd. - Overview
              • Exhibit 111: ADInstruments Pty Ltd. - Product / Service
              • Exhibit 112: ADInstruments Pty Ltd. - Key offerings
            • 12.5 Bruker Corp.
              • Exhibit 113: Bruker Corp. - Overview
              • Exhibit 114: Bruker Corp. - Business segments
              • Exhibit 115: Bruker Corp. - Key offerings
              • Exhibit 116: Bruker Corp. - Segment focus
            • 12.6 CH Technologies USA Inc.
              • Exhibit 117: CH Technologies USA Inc. - Overview
              • Exhibit 118: CH Technologies USA Inc. - Product / Service
              • Exhibit 119: CH Technologies USA Inc. - Key offerings
            • 12.7 Columbus Instruments LLC
              • Exhibit 120: Columbus Instruments LLC - Overview
              • Exhibit 121: Columbus Instruments LLC - Product / Service
              • Exhibit 122: Columbus Instruments LLC - Key offerings
            • 12.8 CWE
              • Exhibit 123: CWE - Overview
              • Exhibit 124: CWE - Product / Service
              • Exhibit 125: CWE - Key offerings
            • 12.9 emka TECHNOLOGIES
              • Exhibit 126: emka TECHNOLOGIES - Overview
              • Exhibit 127: emka TECHNOLOGIES - Product / Service
              • Exhibit 128: emka TECHNOLOGIES - Key offerings
            • 12.10 EMMS
              • Exhibit 129: EMMS - Overview
              • Exhibit 130: EMMS - Product / Service
              • Exhibit 131: EMMS - Key offerings
            • 12.11 Harvard Bioscience Inc.
              • Exhibit 132: Harvard Bioscience Inc. - Overview
              • Exhibit 133: Harvard Bioscience Inc. - Product / Service
              • Exhibit 134: Harvard Bioscience Inc. - Key offerings
            • 12.12 IN TOX PRODUCTS LLC
              • Exhibit 135: IN TOX PRODUCTS LLC - Overview
              • Exhibit 136: IN TOX PRODUCTS LLC - Product / Service
              • Exhibit 137: IN TOX PRODUCTS LLC - Key offerings
            • 12.13 Kent Scientific Corp.
              • Exhibit 138: Kent Scientific Corp. - Overview
              • Exhibit 139: Kent Scientific Corp. - Key offerings
            • 12.14 Lab Products Inc.
              • Exhibit 140: Lab Products Inc. - Overview
              • Exhibit 141: Lab Products Inc. - Product / Service
              • Exhibit 142: Lab Products Inc. - Key offerings
            • 12.15 NuAire Inc.
              • Exhibit 143: NuAire Inc. - Overview
              • Exhibit 144: NuAire Inc. - Product / Service
              • Exhibit 145: NuAire Inc. - Key offerings
            • 12.16 RWD Life Science Co. Ltd.
              • Exhibit 146: RWD Life Science Co. Ltd. - Overview
              • Exhibit 147: RWD Life Science Co. Ltd. - Product / Service
              • Exhibit 148: RWD Life Science Co. Ltd. - Key offerings
            • 12.17 TSE Systems GmbH
              • Exhibit 149: TSE Systems GmbH - Overview
              • Exhibit 150: TSE Systems GmbH - Product / Service
              • Exhibit 151: TSE Systems GmbH - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 152: Inclusions checklist
                • Exhibit 153: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 154: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 155: Research methodology
                • Exhibit 156: Validation techniques employed for market sizing
                • Exhibit 157: Information sources
              • 13.5 List of abbreviations
                • Exhibit 158: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              preclinical respiration and inhalation lab equipment market market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis